Articles published by Cullinan Oncology, Inc.
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology to Participate in Upcoming Investor Conferences
February 27, 2024
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 08, 2023
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology to Present Data Demonstrating Progress Across Its Broad Immunotherapy-Pipeline at SITC 2023
November 03, 2023
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology to Participate in Upcoming Investor Conferences
October 30, 2023
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology to Participate in Upcoming Investor Conferences
September 06, 2023
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 10, 2023
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 14, 2022
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors
November 02, 2022
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Via GlobeNewswire
Tickers
CGEM
![](https://ml.globenewswire.com/media/9c3088b4-428e-4135-8389-cc2e1509b92f/small/co-masterlogo-4x-300-dpi-png.png)
Cullinan Oncology to Participate in Upcoming Investor Conferences
November 01, 2022
Via GlobeNewswire
Tickers
CGEM
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.